Press Release – September 20, 2018
Chaperone Therapeutics Awarded National Institutes of Health Funding for Alzheimer’s Disease Therapeutic Development

Press Release – January 8, 2018
Elyse Bourque appointed Vice President, Medicinal Chemistry at Chaperone

Press Release – September 15, 2017
Chaperone Therapeutics Awarded National Institutes of Health grant to develop therapeutics to slow the progression of Huntington’s disease and other neurodegenerative disorders through restoration of protein folding mechanisms

Press Release – September 6, 2016
Chaperone Therapeutics garners National Institutes of Health Award to validate neuronal protective technology in Noise-Induced Hearing Loss

Press Release – February 8, 2016
Chaperone Therapeutics Founder’s groundbreaking research on Heat Shock Transcription Factors published in Nature journal

Press Release – September 22, 2015
Chaperone Therapeutics and the ALS Therapy Development Institute Host Webinar on Partnership to validate Chaperone’s therapies in Amyotropic Lateral Sclerosis

Press Release – September 04, 2015
Chaperone Therapeutics and Senhwa Biosciences Announce Licensing Deal

Press Release – August 10, 2015
Chaperone Therapeutics and ALS Therapy Development Institute Enter into Research Partnership